Clinical Trial Update: A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topically applied SM04554 for androgenetic alopecia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• SM04554 (SM04554)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Androgenetic Alopecia | Phase 2 | Status: COMPLETED